{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:32:43Z","timestamp":1791462763284,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1136\/ijgc-2023-004534","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T22:15:15Z","timestamp":1695161715000},"page":"1564-1571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Endometrial adenocarcinoma recurring in the lung: impact of molecular profile and role of local therapies on prognosis"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6007-0308","authenticated-orcid":false,"given":"Ana","family":"Luzarraga Aznar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Bebia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"L\u00f3pez-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Giraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MP","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Verges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Jauregui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Castellvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assumpci\u00f3","family":"P\u00e9rez-Benavente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Col\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gil-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3164-6686","authenticated-orcid":false,"given":"Silvia","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2023-004534_bb0010","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2023-004534_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3802\/jgo.2011.22.1.3","article-title":"Multivariate survival analysis of the patients with recurrent endometrial cancer","volume":"22","author":"Odagiri","year":"2011","journal-title":"J Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004534_bb0020","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2217\/fon-2020-0017","article-title":"Clinicopathological study of organ metastasis in endometrial cancer","volume":"16","author":"Mao","year":"2020","journal-title":"Future Oncol"},{"key":"10.1136\/ijgc-2023-004534_bb0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0090-8258(79)90081-7","article-title":"Pulmonary metastases of endometrial carcinoma","volume":"7","author":"Ballon","year":"1979","journal-title":"Gynecologic Oncology"},{"key":"10.1136\/ijgc-2023-004534_bb0030","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3<441::AID-CNCR10>3.0.CO;2-Z","article-title":"Natural history of patients with pulmonary metastases from uterine cancer","volume":"78","author":"Bouros","year":"1996","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2023-004534_bb0035","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/gyno.2000.6058","article-title":"Hematogenous dissemination in Corpus cancer","volume":"80","author":"Mariani","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004534_bb0040","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ygyno.2007.06.030","article-title":"Treatment of pulmonary recurrences in patients with endometrial cancer","volume":"107","author":"Dowdy","year":"2007","journal-title":"Gynecologic Oncology"},{"key":"10.1136\/ijgc-2023-004534_bb0045","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jcma.2015.10.010","article-title":"Pulmonary recurrence in patients with endometrial cancer","volume":"79","author":"Turan","year":"2016","journal-title":"J Chin Med Assoc"},{"key":"10.1136\/ijgc-2023-004534_bb0050","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clon.2012.12.005","article-title":"Lung metastases treated with image-guided stereotactic body radiation therapy","volume":"25","author":"Baschnagel","year":"2013","journal-title":"Clinical Oncology"},{"key":"10.1136\/ijgc-2023-004534_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2012.00181","article-title":"Phase II clinical trial of robotic stereotactic body radiosurgery for metastatic gynecologic malignancies","volume":"2","author":"Kunos","year":"2012","journal-title":"Front Oncol"},{"key":"10.1136\/ijgc-2023-004534_bb0060","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ygyno.2010.11.042","article-title":"Stereotactic body radiotherapy (SBRT): technological innovation and application in gynecologic oncology","volume":"120","author":"Higginson","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004534_bb0065","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"The Lancet"},{"key":"10.1136\/ijgc-2023-004534_bb0070","first-page":"363","article-title":"The prognostic impact of pulmonary metastasectomy in recurrent gynecologic cancers: a retrospective single-institution study","volume":"77","author":"Adachi","year":"2015","journal-title":"Nagoya J Med Sci"},{"key":"10.1136\/ijgc-2023-004534_bb0075","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jtcvs.2003.10.011","article-title":"Pulmonary metastases from uterine malignancies: results of surgical resection in 133 patients","volume":"127","author":"Anraku","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1136\/ijgc-2023-004534_bb0080","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","article-title":"Final validation of the promise molecular classifier for endometrial carcinoma in a large population-based case series","volume":"29","author":"Kommoss","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2023-004534_bb0085","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer\u2014combined analysis of the PORTEC cohorts","volume":"22","author":"Stelloo","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1136\/ijgc-2023-004534_bb0090","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/PAS.0000000000001020","article-title":"Molecular classification of grade 3 endometrioid endometrial cancers identifies distinct prognostic subgroups","volume":"42","author":"Bosse","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1136\/ijgc-2023-004534_bb0095","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2023-004534_bb0100","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ygyno.2022.02.024","article-title":"Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification","volume":"165","author":"Siegenthaler","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004534_bb0105","author":"US Department of Health and Human Services, National Institutes of Health, National Cancer Institute","year":"2017","journal-title":"Common terminology criteria for adverse events (CTCAE) version 5"},{"key":"10.1136\/ijgc-2023-004534_bb0110","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"key":"10.1136\/ijgc-2023-004534_bb0115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004534_bb0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijgo.2009.02.010","article-title":"Revised FIGO staging for carcinoma of the endometrium","volume":"105","author":"Creasman","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2023-004534_bb0125","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/jso.23871","article-title":"Comparable outcome between endometrioid and non-endometrioids tumors in patients with early-stage high-grade endometrial cancer","volume":"111","author":"Reynaers","year":"2015","journal-title":"J Surg Oncol"},{"key":"10.1136\/ijgc-2023-004534_bb0130","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--a pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2023-004534_bb0135","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ygyno.2020.10.001","article-title":"Stereotactic body radiation therapy (SBRT) in recurrent, persistent or oligometastatic gynecological cancers","volume":"159","author":"Reshko","year":"2020","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24017171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24017171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2023-004534","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:41:14Z","timestamp":1753224074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24017171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1048891X24017171"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2023-004534","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endometrial adenocarcinoma recurring in the lung: impact of molecular profile and role of local therapies on prognosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2023-004534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}